Literature DB >> 22134369

Enteroscopic biopsies in the management of pancreas transplants: a proof of concept study for a novel monitoring tool.

Christian Margreiter1, Felix Aigner, Thomas Resch, Anna-Katharina Berenji, Rupert Oberhuber, Robert Sucher, Christoph Profanter, Lothar Veits, Robert Öllinger, Raimund Margreiter, Johann Pratschke, Walter Mark.   

Abstract

BACKGROUND: Although percutaneous biopsies are considered to be the gold standard in diagnosing pancreas graft rejection, they are not performed routinely because of their association with severe complications. On the other hand, correct diagnosis of rejection is essential but may be difficult in cases of enteric drainage, particularly in patients with a pancreas transplant alone or a pancreas after kidney transplant.
METHODS: Pancreas recipients who underwent enteroscopy between May 2005 and September 2009 were included in this retrospective analysis. Biopsies were graded 0 to 4 for interstitial and vascular changes.
RESULTS: During the study period a total of 65 simultaneous pancreas-kidney transplants, 13 pancreas after kidney transplants and 4 pancreas transplants alone were performed. Sixty-three patients underwent a single enteroscopy, 10 had two, and 6 had three or more. Indications were protocol graft monitoring (n=73), graft dysfunction (n=17), enteric hemorrhage (n=9), or other (n=3). The duodenal segment was accessed in 76 instances (75%) with abnormal findings in 23. A total of 69 biopsies were obtained and revealed normal mucosa in 49 cases (71%). Histology showed signs of acute rejection in 11 cases. The upper gastrointestinal tract was also assessed, and, in 13 cases, additional pathologies were identified including gastroduodenitis (n=10), gastric/duodenal ulcer (n=2), and hemorrhagic esophagitis (n=1). No procedure-related complication occurred.
CONCLUSIONS: This series of enteroscopies demonstrates that the duodenal segment of a pancreatic graft is accessible using our implant technique, and thus permitting biopsies to be obtained and endoscopic interventions to be performed.

Entities:  

Mesh:

Year:  2012        PMID: 22134369     DOI: 10.1097/TP.0b013e31823cf953

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

Review 2.  [Pancreas transplantation-clinic, technique, and histological assessment].

Authors:  Maike Büttner-Herold; Kerstin Amann; Frederick Pfister; Andrea Tannapfel; Marina Maslova; Andreas Wunsch; Nina Pillokeit; Richard Viebahn; Peter Schenker
Journal:  Pathologe       Date:  2021-08-20       Impact factor: 1.011

3.  Outcomes of pancreas retransplantation in patients with pancreas graft failure.

Authors:  S Gasteiger; B Cardini; G Göbel; R Oberhuber; F Messner; T Resch; C Bösmüller; C Margreiter; S Schneeberger; M Maglione
Journal:  Br J Surg       Date:  2018-07-14       Impact factor: 6.939

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.